Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis B vaccine (recombinant) (Bharat Biotech)
- Development stage
- Unknown
- Lead developer
- Bharat Biotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Revac-B MCF (also known as Revac-B mcf) is a preservative-free (thiomersal-free) and cesium chloride-free recombinant Hepatitis B vaccine developed and manufactured by Bharat Biotech. It contains purified, non-infectious major surface antigen of the Hepatitis B virus (HBsAg) produced using recombinant DNA technology in yeast (*Pichia pastoris*). The vaccine is adsorbed on aluminum hydroxide to stimulate active immunization against infection caused by all known subtypes of the Hepatitis B virus. It is administered intramuscularly and is particularly indicated for newborns, infants, and individuals at high risk of exposure to Hepatitis B.
- Brand names
- Revac-BRevac-B MCFRevac-B PlusRevac-B+
- Other names
- HBsAg vaccineHepatitis B Vaccine (rDNA)hepatitis B vaccine (recombinant)recombinant hepatitis B vaccine
02
Targets
HBsAg (Hepatitis B virus surface antigen S protein)
Beyond the preview
Go deeper on hepatitis B vaccine (recombinant) (Bharat Biotech).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis B vaccine (recombinant) (Bharat Biotech).